Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Insight buruk dimiliki 80% klien skizofrenia dan efikasi dirinya rendah. Insight buruk menurunkan efikasi diri. Penelitian bertujuan mengetahui pengaruh Terapi Penerimaan dan Komitmen (TPK) dan Program Edukasi Pasien (PEP) terhadap insight dan efikasi diri klien skizofrenia di RSJ Prof. Dr. Soeroyo Magelang. Desain quasi experimental pre-post test with control group. Sampel 147 diambil dengan teknik simple random sampling. Analisis data dengan Kruskall Wallis Test dan Regresi Linear Ganda. Hasil: Insight dan efikasi diri klien skizofrenia yang mendapatkan TPK-PEP meningkat secara bermakna dan lebih tinggi secara bermakna dari klien yang mendapatkan TPK. TPK-PEP meningkatkan insight sebesar 8,741 poin dan efikasi diri 11,522 poin. TPK-PEP direkomendasikan sebagai terapi keperawatan utama dalam merawat klien skizofrenia dengan insight buruk dan efikasi diri rendah. ......Impaired insight and low self-efficacy are common in schizophrenic clients. Bad insight exacerbates self stigma and lowers self-efficacy. This study aimed to determine effect of ACT-PEP on insight and self-efficacy of schizophrenic clients at Prof. Dr. Soeroyo Magelang Hospital. This was a quasiexperimental research, using pre-post test with control group. A number of 147 samples were recruited using simple random sampling technique, divided into 3 groups of ACT-PEP, ACT only and control. Data were analyzed using Kruskall Wallis Test and Linear Regression. Result: insight and self-efficacy of schizophrenia clients who get ACT-PEP was significantly increased and significantly higher than the clients were getting ACT. ACT-PEP increased insight by 8.741 points and increased self-efficacy by 11.522 points. ACT-PEP is recommended as primary therapy in nursing care for clients schizophrenia with poor insight and low self-efficacy.

Abstrak :
Pemantauan terapi obat merupakan suatu proses yang mencakup kegiatan untuk memastikan terapi obat yang aman, efektif dan rasional. Pemantauan terapi obat mencakup pengkajian pilihan obat, dosis cara pemberian obat, respons terapi dan rekomendasi perubahan atau alternatif terapi. Pemantauan terapi obat harus dilakukan secara berkesinambungan dan dievaluasi secara teratur pada periode tertentu agar keberhasilan ataupun kegagalan terapi dapat diketahui. Pasien yang mendapatkan terapi obat mempunyai risiko mengalami masalah terkait obat. Kompleksitas penyakit dan penggunaan obat, serta respons pasien yang sangat individual meningkatkan munculnya masalah terkait obat. Seorang apoteker memiliki peran untuk memantau pemberian intervensi obat dalam penatalaksanaan terapi penyakit bronkopneumonia. Khususnya dalam kasus pada pasien By. D di ruang perawatan pediatric Intensive Care Unit (PICU) RSUD Tarakan Jakarta dengan diagnosa utama bronkopneumonia dan diagnosa penyerta penyakit anemia mikrositik hipokromik. Pemilihan kasus pasien By. D dalam pelaksanaan kegiatan pemantauan terapi ini merujuk pada pengevaluasian terapi bronkoneumonia di ruang perawatan pediatric Intensive Care Unit (PICU) RSUD Tarakan Jakarta. ......Drug therapy monitoring is a process that includes activities to ensure safe, effective and rational drug therapy. Drug therapy monitoring includes an assessment of drug choice, dose of drug administration, therapeutic response and recommendations for changes or alternatives to therapy. Drug therapy monitoring must be carried out continuously and evaluated regularly at certain periods so that the success or failure of therapy can be known. Patients receiving drug therapy are at risk of developing drug-related problems. The complexity of the disease and drug use, as well as highly individualized patient responses increase the occurrence of drug-related problems. A pharmacist has a role to monitor the administration of drug interventions in the management of bronchopneumonia disease therapy. Especially in the case of patient By. D in the pediatric intensive care unit (PICU) of RSUD Tarakan Jakarta with a primary diagnosis of bronchopneumonia and a co-diagnosis of hypochromic microcytic anemia. The case selection of patient By. D in the implementation of this therapy monitoring activity refers to evaluating bronchoneumonia therapy in the pediatric intensive care unit (PICU) of RSUD Tarakan Jakarta.